Patents by Inventor Daniel DEVRIES

Daniel DEVRIES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240304352
    Abstract: A method and a system for eluting a desired activity concentration of a daughter radionuclide-containing eluate obtained from a mixture of mother/daughter radionuclides is disclosed. The method comprises contacting separation particles with an aqueous solution containing a mixture of mother and daughter radionuclides wherein daughter radionuclides bind to separation particles and mother radionuclides does not. That contact is maintained for a time for unbound daughter radionuclide to bind to the separation particles. The unbound mother radionuclide is separated from the daughter radionuclide-bound separation particles using a washing solution. A first fractional amount of the bound daughter radionuclide is stripped from the separation particles using a volume of stripping solution so that an aqueous eluate solution having a desired daughter radionuclide activity is obtained.
    Type: Application
    Filed: November 17, 2023
    Publication date: September 12, 2024
    Applicant: Northstar Medical Technologies, LLC
    Inventors: James T. HARVEY, Daniel DEVRIES, Glenn H. ISENSEE, Dorian LUST, Erik BLUEMNER
  • Publication number: 20240239686
    Abstract: A method for enhancing radionuclide activity of a daughter radionuclide-containing eluate obtained from a mixture of mother/daughter radionuclides is disclosed. This method comprises i) contacting separation particles with an aqueous solution containing a mixture of mother and daughter radionuclides wherein daughter radionuclides bind to separation particles and mother radionuclides does not. That contact is maintained ii) for a time for unbound daughter radionuclide to bind to the separation particles. Unbound mother radionuclide is iii) separated from the daughter radionuclide-bound separation particles using a washing solution. Steps i) and ii) are repeated at least once iv). The bound daughter radionuclide is stripped v) from the separation particles using a volume of stripping solution less than that used if only steps i), ii), iii) and v) were used for each of the recited at least two separations to form an aqueous eluate having enhanced daughter radionuclide activity.
    Type: Application
    Filed: November 17, 2023
    Publication date: July 18, 2024
    Applicant: Northstar Medical Technologies, LLC
    Inventors: James T. HARVEY, Glenn H. ISENSEE, Daniel DEVRIES, Tyler Drum